World Wide Web | Some researchers in Britain revealed they are investigating whether drug addict who loved nightclubs, ecstasy, can be effective in treating patients with blood cancer.
Some health scientists at the University of Birmingham in the central part of England said it was a form of medicine that has been altered encourage the ability to destroy cancer cells up to 100 times more powerful.
Six years ago, some researchers find cancer that attacks white blood cells seem to react to certain drugs on the "psychotropic".
These include weight loss medication, anti-depressant Prozac type, and amphetamine derivatives such as MDMA - which by the general public known as ecstasy, Friday (19/8).
The scientists say their findings in Birmingham since it could lead to MDMA derivatives are now used in experiments on patients. The derivatives may be effective in treating blood cancers such as leukemia, lymphoma, and myeloma.
"This is an exciting step toward the continued use of a modified form of MDMA to help people suffering from blood cancer," said Professor John Gordon, from the School of Immunology and Infection at the University of Birmingham, as quoted by AFP.
"Although we do not intend to give people false hope, the results of this research have the potential to increase treatment in the next few years," he said.
The team found that the dose of MDMA required to treat a tumor would prove fatal, so they plan to isolate womb cancer killer in the drug.
They are now researching how to make MDMA molecules to penetrate cancer cell walls with ease.
Doctor David Grant, Scientific Director at the charity Leukaemia and Lymphoma Research - which funded part of the study, said, "The prospect to be able to target blood cancer with a drug that is made from pernyataanyang ecstasy is very exciting."
"Many types of lymphoma remain hard to treat and non-toxic drugs which are very effective and have the necessary impact," he added.
The findings are published in the bi-monthly journal Investigational New Drugs.
No comments:
Post a Comment